Updated: Jul 21, 2024
The average Halozyme Therapeutics stock price target is 59.71 with a max estimate of 72.00 and a min estimate of 51.00
Review Halozyme Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Jul 21, 2024